Bcg2 Health and Spitfire have snaffled a couple more Pfizer brands, after the two combined forces to win the haemophilia treatments pitch for the Xyntha and BeneFIX products in the Australian market against two Aussie agencies. This win adds to the New Zealand haemophilia business that was won in November last year.General manager of bcg2 Health, Stuart Ogden, said the two agencies worked together to provide “a perfect blend of specialist healthcare knowledge and communication skills, combined with specialist digital strategy and production”.